VentriPoint Diagnostics Ltd. (VPT.V)
CAD 0.14
(3.85%)
CAD 0.14
(3.85%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.69 Million CAD | 19.01% |
| 2022 | 1.42 Million CAD | 17.54% |
| 2021 | 1.21 Million CAD | -61.56% |
| 2020 | 3.15 Million CAD | 13.17% |
| 2019 | 2.78 Million CAD | 93.35% |
| 2018 | 1.43 Million CAD | -56.84% |
| 2017 | 3.33 Million CAD | 14.16% |
| 2016 | 2.92 Million CAD | 19.31% |
| 2015 | 2.44 Million CAD | -15.17% |
| 2014 | 2.88 Million CAD | -25.62% |
| 2013 | 3.88 Million CAD | 1.49% |
| 2012 | 3.82 Million CAD | -19.83% |
| 2011 | 4.77 Million CAD | 86.28% |
| 2010 | 2.56 Million CAD | -26.05% |
| 2009 | 3.46 Million CAD | 53.25% |
| 2008 | 2.26 Million CAD | 278.51% |
| 2007 | 597.11 Thousand CAD | 6161.83% |
| 2006 | 9535.77 CAD | 67.67% |
| 2005 | 5687.38 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.77 Million CAD | 4.89% |
| 2024 Q2 | 2.72 Million CAD | 53.25% |
| 2023 Q4 | 1.69 Million CAD | 5.7% |
| 2023 Q1 | 1.47 Million CAD | 3.6% |
| 2023 Q3 | 1.6 Million CAD | 7.06% |
| 2023 Q2 | 1.49 Million CAD | 1.5% |
| 2023 FY | 1.69 Million CAD | 19.01% |
| 2022 Q3 | 1.16 Million CAD | -8.02% |
| 2022 Q1 | 1.07 Million CAD | -11.2% |
| 2022 Q2 | 1.26 Million CAD | 17.8% |
| 2022 FY | 1.42 Million CAD | 17.54% |
| 2022 Q4 | 1.42 Million CAD | 22.16% |
| 2021 Q3 | 1.39 Million CAD | 1.55% |
| 2021 Q4 | 1.21 Million CAD | -13.4% |
| 2021 Q2 | 1.37 Million CAD | -38.77% |
| 2021 Q1 | 2.24 Million CAD | -28.61% |
| 2021 FY | 1.21 Million CAD | -61.56% |
| 2020 FY | 3.15 Million CAD | 13.17% |
| 2020 Q2 | 3.44 Million CAD | 7.99% |
| 2020 Q1 | 3.19 Million CAD | 14.76% |
| 2020 Q3 | 3.15 Million CAD | -8.55% |
| 2020 Q4 | 3.15 Million CAD | -0.15% |
| 2019 Q3 | 2.99 Million CAD | 4.57% |
| 2019 FY | 2.78 Million CAD | 93.35% |
| 2019 Q1 | 2.74 Million CAD | 90.88% |
| 2019 Q2 | 2.86 Million CAD | 4.36% |
| 2019 Q4 | 2.78 Million CAD | -7.18% |
| 2018 Q2 | 2.08 Million CAD | -12.44% |
| 2018 FY | 1.43 Million CAD | -56.84% |
| 2018 Q1 | 2.37 Million CAD | -28.68% |
| 2018 Q3 | 1.31 Million CAD | -36.8% |
| 2018 Q4 | 1.43 Million CAD | 9.34% |
| 2017 Q2 | 4.24 Million CAD | -42.79% |
| 2017 Q4 | 3.33 Million CAD | 22.09% |
| 2017 FY | 3.33 Million CAD | 14.16% |
| 2017 Q1 | 7.41 Million CAD | 153.74% |
| 2017 Q3 | 2.73 Million CAD | -35.59% |
| 2016 Q1 | 1.83 Million CAD | -25.13% |
| 2016 FY | 2.92 Million CAD | 19.31% |
| 2016 Q4 | 2.92 Million CAD | 20.97% |
| 2016 Q3 | 2.41 Million CAD | 14.28% |
| 2016 Q2 | 2.11 Million CAD | 15.27% |
| 2015 Q2 | 3.51 Million CAD | 4.5% |
| 2015 FY | 2.44 Million CAD | -15.17% |
| 2015 Q1 | 3.36 Million CAD | 16.58% |
| 2015 Q4 | 2.44 Million CAD | -25.58% |
| 2015 Q3 | 3.29 Million CAD | -6.44% |
| 2014 Q3 | 3.01 Million CAD | -14.43% |
| 2014 FY | 2.88 Million CAD | -25.62% |
| 2014 Q4 | 2.88 Million CAD | -4.27% |
| 2014 Q2 | 3.52 Million CAD | -8.4% |
| 2014 Q1 | 3.84 Million CAD | -0.86% |
| 2013 Q1 | 3.74 Million CAD | -2.2% |
| 2013 FY | 3.88 Million CAD | 1.49% |
| 2013 Q3 | 5.59 Million CAD | 41.56% |
| 2013 Q4 | 3.88 Million CAD | -30.64% |
| 2013 Q2 | 3.95 Million CAD | 5.69% |
| 2012 FY | 3.82 Million CAD | -19.83% |
| 2012 Q1 | 3.45 Million CAD | -27.53% |
| 2012 Q2 | 4.26 Million CAD | 23.43% |
| 2012 Q3 | 4.19 Million CAD | -1.72% |
| 2012 Q4 | 3.82 Million CAD | -8.81% |
| 2011 Q1 | 4.16 Million CAD | 62.44% |
| 2011 FY | 4.77 Million CAD | 86.28% |
| 2011 Q4 | 4.77 Million CAD | -14.68% |
| 2011 Q3 | 5.59 Million CAD | 20.04% |
| 2011 Q2 | 4.65 Million CAD | 11.97% |
| 2010 Q2 | 3.18 Million CAD | -6.35% |
| 2010 Q4 | 2.56 Million CAD | -24.68% |
| 2010 FY | 2.56 Million CAD | -26.05% |
| 2010 Q1 | 3.4 Million CAD | -1.81% |
| 2010 Q3 | 3.4 Million CAD | 6.76% |
| 2009 FY | 3.46 Million CAD | 53.25% |
| 2009 Q2 | 3.13 Million CAD | -1.69% |
| 2009 Q1 | 3.19 Million CAD | 41.22% |
| 2009 Q4 | 3.46 Million CAD | 6.74% |
| 2009 Q3 | 3.24 Million CAD | 3.42% |
| 2008 Q3 | 995.92 Thousand CAD | 27.13% |
| 2008 Q4 | 2.26 Million CAD | 126.94% |
| 2008 FY | 2.26 Million CAD | 278.51% |
| 2008 Q1 | 795.5 Thousand CAD | 33.23% |
| 2008 Q2 | 783.4 Thousand CAD | -1.52% |
| 2007 FY | 597.11 Thousand CAD | 6161.83% |
| 2007 Q2 | 6602.03 CAD | -59.77% |
| 2007 Q3 | 990.46 Thousand CAD | 14902.39% |
| 2007 Q4 | 597.11 Thousand CAD | -39.71% |
| 2007 Q1 | 16.41 Thousand CAD | 72.11% |
| 2006 Q3 | 5850.98 CAD | -9.38% |
| 2006 Q4 | 9535.77 CAD | 62.98% |
| 2006 FY | 9535.77 CAD | 67.67% |
| 2006 Q1 | 6107.63 CAD | 0.0% |
| 2006 Q2 | 6456.79 CAD | 5.72% |
| 2005 FY | 5687.38 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | 7.09 Million CAD | 76.129% |
| Therma Bright Inc. | 2.16 Million CAD | 21.761% |
| Theralase Technologies Inc. | 1.37 Million CAD | -23.503% |